Biocept and Insight Genetics to Present ALK Expression Study Data on Liquid Biopsy Platform at the IASLC World Conference on Lung Cancer
Detection of ALK biomarker expression in circulating tumor cells could provide a new method to identify and monitor patients with ALK+ lung cancer
Earlier this year,
"These data further support Biocept's ability to scale our liquid biopsy
platform across a number of different biomarkers," said
"Through our collaboration of combining Biocept's CTC capture platform
and Insight Genetics' ALK qPCR assay, we have been able to successfully
detect ALK fusions from blood, something only dreamed about just a few
years ago," said
About the
About
Forward-Looking Statements Disclaimer Statement
This release contains forward-looking statements that are based upon
current expectations or beliefs, as well as a number of assumptions
about future events. Although we believe that the expectations reflected
in the forward-looking statements and the assumptions upon which they
are based are reasonable, we can give no assurance that such
expectations and assumptions will prove to have been correct.
Forward-looking statements are generally identifiable by the use of
words like "may," "will," "should," "could," "expect," "anticipate,"
"estimate," "believe," "intend," or "project" or the negative of these
words or other variations on these words or comparable terminology. To
the extent that statements in this release are not strictly historical,
including without limitation statements as to our ability to accurately
monitor biomarker status in NSCLC patient populations, our ability to
continue to scale our liquid biopsy platform across a number of
different biomarkers, our ability to make clinical testing from liquid
biopsies standard of care, and planned future offerings, such statements
are forward-looking, and are made pursuant to the safe harbor provisions
of the Private Securities Litigation Reform Act of 1995. The reader is
cautioned not to put undue reliance on these forward-looking statements,
as these statements are subject to numerous risk factors as set forth in
our
View source version on businesswire.com: http://www.businesswire.com/news/home/20150903005394/en/
Investors:
LHA
jcain@lhai.com
Source:
News Provided by Acquire Media